Loading company profile …

Pricing Privacy Cookies

NORGENOTECH AS

← Back to search

NORGENOTECH AS

Org.nr. 897 365 812 · Private limited company (AS) · OSLO

Analyze

Key figures 2025

Revenue

NOK 2.7m

▲ 268%

Operating profit

NOK 31.2k

▲ 112.6%

Net profit

-NOK 62.8k

▲ 69.8%

Equity

NOK 229.1k

▼ 21.5%

Employees: Not registered
Revenue per employee: Cannot be calculated
Operating margin: 1.2%
Age: 15 years

Source: Regnskapsregisteret (Brønnøysundregistrene) · Fetched 27/10/2026, 15:19

AI analysis

A short assessment of the company from public register data: strengths, risks, opportunities and what to ask.

Creating the analysis …

Key information

Chief executive

Financial health 2025

Profitability

1.1%

Weak

Solidity

8.1%

Weak

Liquidity

Roles

Board: Sergey Shaposhnikov (b. 1974) – Chair of the board
Gunnar Christian Brøvig (b. 1946) – Board member
Gunnar Brunborg (b. 1947) – Board member
Andrew Richard Sherman Collins (b. 1946) – Board member
Accountant: REGNSKAPPLUSS AS – Accountant

Person profiles with every company a person has roles in are coming soon.

Source: Enhetsregisteret (Brønnøysundregistrene) · Fetched 27/10/2026, 15:19

People

People with roles in this company, and the other companies they have roles in.

Andrew Richard Sherman Collins (b. 1946)
Here: Board member
Also has roles in
- COMET BIOTECH ASGeneral manager
Gunnar Brunborg (b. 1947)
Here: Board member
Also has roles in
Gunnar Christian Brøvig (b. 1946)
Here: Board member
Also has roles in

Not registered

Industry

72.100 Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk

Address

Ullernchausséen 64, 0379 OSLO

Employees

Not registered

Founded

14 August 2011

Website

www.norgenotech.no

Contact details

Phone and email registered. Log in to see

Auditor

Not registered

Accountant

REGNSKAPPLUSS AS

Purpose / activity (in Norwegian)

Utvikle og kommersialisere innovative metoder innen bioteknologi, samt annet som står i forbindelse med dette. Videre er formålet å investere i selskap som driver innen samme næring. Slike investeringer skal godkjennes av selskapets generalforsamling med 2/3 (to-tredjedelers) flertall.

More company details

Organisation number: 897 365 812
Legal form: Private limited company (AS) (AS)
Registered in the Central Coordinating Register: 20 September 2011
Sector: Private aksjeselskaper mv.
VAT register: Registered
Register of Business Enterprises: Registered
Latest annual accounts filed: 2025
Business address: Ullernchausséen 64, 0379 OSLO
Postal address: c/o Sergey Shaposhnikov, Hanåveien 146, 1290 OSLO
Municipality: OSLO

Source: Enhetsregisteret (Brønnøysundregistrene) · Fetched 27/10/2026, 15:19

1.02

Satisfactory

Accounts

Annual revenue

NOK 2.7m▲ 268%

3.3M

2023

722k

2024

2.7M

2025

Results and balance sheet

2025 · vs 2024

Operating profit: NOK 31.2k▲ 112.6%-NOK 248.2k
Profit before tax: NOK 5.8k▲ 102.2%-NOK 258.1k
Net profit: -NOK 62.8k▲ 69.8%-NOK 208.2k
Equity: NOK 229.1k▼ 21.5%NOK 291.9k
Total assets: NOK 2.8m▲ 247.8%NOK 811k
Total liabilities: NOK 2.6m▲ 399.2%NOK 519.1k

Source: Regnskapsregisteret (Brønnøysundregistrene) · Fetched 27/10/2026, 15:19

COMET BIOTECH ASChair of the board

Sergey Shaposhnikov (b. 1974)

Here: Chair of the board

Also has roles in

COMET BIOTECH ASBoard member
SPRING BIOLAB ASGeneral manager, Chair of the board

Companies

No companies are connected to this entity through roles.

Owners (shareholders) are not in the business register but in the Norwegian Tax Administration's shareholder register. Coming later.

People are matched on name and date of birth from the register, never on name alone. Source: Register of roles (Brønnøysundregistrene) · Fetched 25/10/2026, 22:59

AI analysis

A short assessment of the company from public register data: strengths, risks, opportunities and what to ask.